Tenet Healthcare (NYSE:THC) Reaches New 12-Month High – Should You Buy?

Tenet Healthcare Corporation (NYSE:THC)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $236.18 and last traded at $232.79, with a volume of 167516 shares trading hands. The stock had previously closed at $233.77.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on THC shares. Royal Bank Of Canada raised their price objective on Tenet Healthcare from $253.00 to $277.00 and gave the stock an “outperform” rating in a research note on Thursday, February 12th. Wells Fargo & Company reissued an “overweight” rating and issued a $265.00 price objective on shares of Tenet Healthcare in a report on Monday, February 16th. Barclays boosted their price target on Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a report on Friday, February 13th. Jefferies Financial Group increased their price target on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Finally, UBS Group upped their price target on Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $247.67.

Tenet Healthcare Stock Performance

The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The firm’s 50 day moving average is $202.61 and its 200-day moving average is $198.19. The company has a market cap of $20.26 billion, a PE ratio of 15.04, a PEG ratio of 1.13 and a beta of 1.45.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same period in the prior year, the business earned $3.44 earnings per share. The business’s revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, research analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Insider Activity at Tenet Healthcare

In other news, Director Nadja West sold 2,178 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the transaction, the director directly owned 28,480 shares in the company, valued at approximately $5,623,945.60. This represents a 7.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.81% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Tenet Healthcare

Large investors have recently made changes to their positions in the stock. Norges Bank acquired a new position in Tenet Healthcare during the fourth quarter worth $248,494,000. Eminence Capital LP purchased a new stake in Tenet Healthcare during the 3rd quarter worth approximately $225,263,000. Boston Partners grew its stake in shares of Tenet Healthcare by 95.0% in the second quarter. Boston Partners now owns 2,267,142 shares of the company’s stock worth $398,949,000 after acquiring an additional 1,104,500 shares in the last quarter. Wellington Management Group LLP grew its stake in Tenet Healthcare by 1,114.2% during the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock worth $225,706,000 after purchasing an additional 1,042,260 shares in the last quarter. Finally, AQR Capital Management LLC grew its position in shares of Tenet Healthcare by 62.3% during the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after buying an additional 720,160 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.